Extracorporeal hemoadsorption with the CytoSorb device as a potential therapeutic option in severe intoxications: Review of the rationale and current clinical experiences
- 3 August 2022
- journal article
- editorial
- Published by Wiley in Journal of Clinical Pharmacy and Therapeutics
- Vol. 47 (9) , 1444-1451
Abstract
Many severe intoxications occur with substances with no specific antidote, which is why methods of extracorporeal elimination represent a particularly useful and even critical component in their management. The purpose of this review is to summarize the accumulating evidence and clinical results from the application of CytoSorb hemoadsorption therapy in patients with severe intoxications. The technology represents a promising technique with an increasing number of publications in a variety of severe intoxication scenarios suggesting that early intervention might provide rapid substance removal with subsequent overall clinical improvement. Given the tremendous challenges in performing prospective, randomized trials in this field, the strong safety profile of the device and the high acuity of these life-threatening situations, CytoSorb should be considered as a therapeutic option in severe intoxications, particularly when direct antidotes are not available. However, further clinical data are desirable to provide precise recommendations.Keywords
This publication has 19 references indexed in Scilit:
- Severe quetiapine voluntary overdose successfully treated with a new hemoperfusion sorbentThe International Journal of Artificial Organs, 2019
- Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trialCritical Care, 2019
- Hemoadsorption with CytoSorb®Intensive Care Medicine, 2018
- First-in-Man Fully Percutaneous Complete Bypass of Heart and LungJACC: Cardiovascular Interventions, 2017
- Venlafaxine Intoxication with Development of Takotsubo Cardiomyopathy: Successful Use of Extracorporeal Life Support, Intravenous Lipid Emulsion and Cytosorb®The International Journal of Artificial Organs, 2017
- The Role of Renal Replacement Therapy in the Management of Pharmacologic PoisoningsInternational Journal of Nephrology, 2016
- Effect of hemoadsorption during cardiopulmonary bypass surgery – a blinded, randomized, controlled pilot study using a novel adsorbentCritical Care, 2016
- Digoxin-specific antibody fragments in the treatment of digoxin toxicityClinical Toxicology, 2014
- Continuous Renal Replacement Therapy Does Not Have a Clear Role in the Treatment of PoisoningNephron Clinical Practice, 2010
- Emergency Management of Poisoning2007